Occlusal Trauma and Bisphosphonate-Related Osteonecrosis of the Jaw in Mice

Calcif Tissue Int. 2022 Mar;110(3):380-392. doi: 10.1007/s00223-021-00916-2. Epub 2021 Sep 27.

Abstract

Osteonecrosis of the jaw (ONJ) is a serious adverse event that is associated with antiresorptive agents, and it manifests as bone exposure in the maxillofacial region. Previous clinical reports suggest that mechanical trauma would trigger ONJ in a manner that is similar to tooth extractions. To the best of our knowledge, there have been few detailed pathophysiological investigations of the mechanisms by which occlusal/mechanical trauma influences ONJ. Here, we developed a novel mouse model that exhibits ONJ following experimental hyperocclusion and nitrogen-containing bisphosphonate (N-BP) treatment. This in vivo model exhibited ONJ in alveolar bone, particularly in the mandible. Moreover, the experimental hyperocclusion induced remarkable alveolar bone resorption in both mouse mandible and maxilla, whereas N-BP treatment completely prevented alveolar bone resorption. In this study, we also modeled trauma by exposing clumps of mesenchymal stem cells (MSCs)/extracellular matrix complex to hydrostatic pressure in combination with N-BP. Hydrostatic pressure loading induced lactate dehydrogenase (LDH) release by calcified cell clumps that were differentiated from MSCs; this LDH release was enhanced by N-BP priming. These in vivo and in vitro models may contribute further insights into the effect of excessive mechanical loading on ONJ onset in patients with occlusal trauma.

Keywords: 3D culture; Bisphosphonate; Hydrostatic pressure; Hyperocclusive state; Occlusal trauma; Osteonecrosis of the jaw.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bisphosphonate-Associated Osteonecrosis of the Jaw* / drug therapy
  • Bone Density Conservation Agents* / adverse effects
  • Bone Resorption* / drug therapy
  • Dental Occlusion, Traumatic* / drug therapy
  • Diphosphonates / therapeutic use
  • Humans
  • Mandible
  • Mice
  • Osteonecrosis*

Substances

  • Bone Density Conservation Agents
  • Diphosphonates